SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (4241)5/6/1998 1:08:00 PM
From: Todd N  Respond to of 6136
 
I agree and think 47 is in the ballpark for 12 mos., though I'm hoping for higher. It is nice to get the additional coverage.

My average is around 40 and have been holding a year so far. Jeesh, from 40 to 47 is not even a 20% return for two years of holding, which is pretty lame in this bull market, considering the risks.

If I remember right, 47 was about the price when AGPH turned profitable last year. I guess the idea is to never invest in a PROFITABLE biotech company.<GGG>

Regards,

Todd



To: Steve Fancy who wrote (4241)5/6/1998 4:14:00 PM
From: Steve Fancy  Read Replies (1) | Respond to of 6136
 
Well, without the excitement of the week, we probably would have been in the twenties by now. Tomorrow is looking bad. Not too many folks seem to have been watching, but Asia has been tanking the last few nights, and disaster is being suggested for tonight.

sf


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News